UC Hosts Colorectal Cancer Education Event

The University of Cincinnati (UC) Cancer Center will host “Trauma to Triumph,” a free educational event on colorectal cancer on Thursday, Nov. 10, from 6 p.m. to 8 p.m. at the Vontz Center for Molecular Studies, Martin Luther King Boulevard and Eden Avenue.

Edward Leigh, a nationally known motivational speaker and cancer survivor, will describe how his life was changed and he gained strength from his experience with advanced colon cancer.  

After the presentation, UC medical oncologist Malek Safa, MD, and surgical oncologist Syed Ahmad, MD, will discuss the latest colon cancer treatments and answer questions. 

Colorectal cancer is the second leading cause of cancer-related death in the United States. The American Cancer Society estimates that nearly 147,000 people will be diagnosed with colon or rectal cancer in 2005, and about 38 percent will die from it.

When diagnosed early, colon cancer has a 90 percent cure rate. Research has shown that regular exercise, a healthy diet that includes vitamin D and avoiding cigarettes reduce the risk for the disease.

For more information, call Rachel Whisner at (513) 558-8624. The event is sponsored by Pfizer Pharmaceuticals, Colon Cancer Alliance and UC Cancer Center.

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.